14beta-Hydroxybaccatin III, a compound with limited availability by natural sources, is the starting material for the synthesis of the second-generation anticancer taxoid ortataxel. The 7-tertbutoxycarbonyl- (1a) and 7-triethylsilyl (1b) derivatives of 14beta-hydroxybaccatin III 1,14-carbonate were synthesized from 10-deacetylbaccatin III (3). The crucial steps were (a) the C(14)beta hydroxylation of the corresponding 13-oxobaccatin III derivatives by oxaziridine-mediated electrophilic oxidation and (b) the reduction of the C-13 carbonyl group with sodium or alkylammonium borohydrides. This protocol provides a practical way for the semisynthesis of ortataxel from 10-deacetylbaccatin III, a compound readily available from various yews.

Diastereoselective 14 beta-hydroxylation of baccatin III derivatives

Battaglia A;Guerrini A;
2003

Abstract

14beta-Hydroxybaccatin III, a compound with limited availability by natural sources, is the starting material for the synthesis of the second-generation anticancer taxoid ortataxel. The 7-tertbutoxycarbonyl- (1a) and 7-triethylsilyl (1b) derivatives of 14beta-hydroxybaccatin III 1,14-carbonate were synthesized from 10-deacetylbaccatin III (3). The crucial steps were (a) the C(14)beta hydroxylation of the corresponding 13-oxobaccatin III derivatives by oxaziridine-mediated electrophilic oxidation and (b) the reduction of the C-13 carbonyl group with sodium or alkylammonium borohydrides. This protocol provides a practical way for the semisynthesis of ortataxel from 10-deacetylbaccatin III, a compound readily available from various yews.
2003
Istituto per la Sintesi Organica e la Fotoreattivita' - ISOF
68
9773
9779
TAXOL ANALOGS
RESISTANCE
Reduction
La 14beta-idrossibaccatina III veniva fino ad ora esclusivamente estratta da una unica specie di tasso, il taxus hymalaiensis, in quantità estremamente limitate e non sufficienti per una produzione a livello industriale. La 14beta-idrossibaccatina III è l'intermedio chiave per la sintesi di una famiglia di tassani, i 14beta-idrossi-1,14-carbonati, potenti antitumorali nei riguardi di lineee cellulari tumorali resistenti al tassolo ed altri farmaci (daunomicina, cis-platino, etc). Il composto principale "Ortataxel" (licenza Bayer) è ora in fase II. La procedura da noi sviluppata permette quindi la sintesi industriale dell'Ortataxel. La Metodologia è stata brevettata con brevetto internazionale
9
info:eu-repo/semantics/article
262
Battaglia, A; Baldelli, E; Bombardelli, E; Carenzi, G; Fontana, G; Gambini, A; Gelmi, Ml; Guerrini, A; Pocar, D
01 Contributo su Rivista::01.01 Articolo in rivista
none
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.14243/32251
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact